Articles written by: Jacqueline McKee

Dova Pharmaceuticals Inc. (DOVA) and Teligent Inc. (NASDAQ:TLGT) Contrasting side by side

As Biotechnology businesses, Dova Pharmaceuticals Inc. (NASDAQ:DOVA) and Teligent Inc. (NASDAQ:TLGT), are affected by contrast. This especially applies to their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dova Pharmaceuticals Inc. 28 0.00 N/A […]

Reviewing Mexico Equity & Income Fund Inc. (MXE)’s and New Mountain Finance Corporation (NYSE:NMFC)’s results

As Asset Management companies, Mexico Equity & Income Fund Inc. (NYSE:MXE) and New Mountain Finance Corporation (NYSE:NMFC) are our subject to compare. And more specifically their risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]

Reviewing Neuberger Berman MLP Income Fund Inc. (NML)’s and Pioneer Diversified High Income Trust (NYSE:HNW)’s results

This is a contrast between Neuberger Berman MLP Income Fund Inc. (NYSE:NML) and Pioneer Diversified High Income Trust (NYSE:HNW) based on their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation. The two companies are Asset Management and they also compete with each other. Earnings & Valuation Gross Revenue […]

Sangamo Therapeutics Inc. (SGMO)’s Financial Results Comparing With OPKO Health Inc. (NASDAQ:OPK)

As Biotechnology companies, Sangamo Therapeutics Inc. (NASDAQ:SGMO) and OPKO Health Inc. (NASDAQ:OPK) are our subject to contrast. And more specifically their institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sangamo Therapeutics Inc. 9 0.43 […]

Comparison of TCR2 Therapeutics Inc. (TCRR) and Spero Therapeutics Inc. (NASDAQ:SPRO)

Both TCR2 Therapeutics Inc. (NASDAQ:TCRR) and Spero Therapeutics Inc. (NASDAQ:SPRO) are Biotechnology companies, competing one another. We will compare their dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TCR2 Therapeutics Inc. 15 0.00 9.67M […]

Corbus Pharmaceuticals Holdings Inc. (CRBP)’s Financial Results Comparing With BioPharmX Corporation (NYSEAMERICAN:BPMX)

This is a contrast between Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) and BioPharmX Corporation (NYSEAMERICAN:BPMX) based on their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation. The two companies are Biotechnology and they also compete with each other. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Kindred Biosciences Inc. (KIN)’s Financial Results Comparing With Rigel Pharmaceuticals Inc. (NASDAQ:RIGL)

Since Kindred Biosciences Inc. (NASDAQ:KIN) and Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affect the analyst recommendations, profitability, institutional ownership, risk, dividends, earnings and valuation of both companies. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Mereo BioPharma Group plc (MREO)’s Financial Results Comparing With Vical Incorporated (:)

This is a contrast between Mereo BioPharma Group plc (NASDAQ:MREO) and Vical Incorporated (:) based on their institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation. The two companies are Biotechnology and they also compete with each other. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]